OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol

Louise Bach Callesen; Torben Frøstrup Hansen; Rikke Fredslund Andersen; Niels Pallisgaard; Stine Kramer; Sven Schlander; Søren Rafael Rafaelsen; Anders Kindberg Boysen; Lars Henrik Jensen; Anders Jakobsen; Karen Lise Garm Spindler

doi:10.1080/0284186X.2022.2116728

OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol

Louise Bach Callesen^*, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen Lise Garm Spindler

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Original language	English
Journal	Acta Oncologica
Volume	61
Issue number	9
Pages (from-to)	1152-1156
ISSN	0284-186X
DOIs	https://doi.org/10.1080/0284186X.2022.2116728
Publication status	Published - Sept 2022

Keywords

Circulating Tumor DNA
Clinical Trials, Phase II as Topic
Colorectal Neoplasms/drug therapy
Follow-Up Studies
Humans
Patient Selection

Documents & Links

10.1080/0284186X.2022.2116728

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Callesen, L. B., Hansen, T. F., Andersen, R. F., Pallisgaard, N., Kramer, S., Schlander, S., Rafaelsen, S. R., Boysen, A. K., Jensen, L. H., Jakobsen, A., & Spindler, K. L. G. (2022). OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol. Acta Oncologica, 61(9), 1152-1156. https://doi.org/10.1080/0284186X.2022.2116728

@article{e7536e0ad869438ab9587629bf38d2a9,

title = "OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol",

keywords = "Circulating Tumor DNA, Clinical Trials, Phase II as Topic, Colorectal Neoplasms/drug therapy, Follow-Up Studies, Humans, Patient Selection",

author = "Callesen, {Louise Bach} and Hansen, {Torben Fr{\o}strup} and Andersen, {Rikke Fredslund} and Niels Pallisgaard and Stine Kramer and Sven Schlander and Rafaelsen, {S{\o}ren Rafael} and Boysen, {Anders Kindberg} and Jensen, {Lars Henrik} and Anders Jakobsen and Spindler, {Karen Lise Garm}",

year = "2022",

month = sep,

doi = "10.1080/0284186X.2022.2116728",

language = "English",

volume = "61",

pages = "1152--1156",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "9",

}

Callesen, LB, Hansen, TF , Andersen, RF, Pallisgaard, N, Kramer, S, Schlander, S, Rafaelsen, SR, Boysen, AK, Jensen, LH, Jakobsen, A & Spindler, KLG 2022, 'OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol', Acta Oncologica, vol. 61, no. 9, pp. 1152-1156. https://doi.org/10.1080/0284186X.2022.2116728

OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer: a ctDNA-guided phase II randomised approach. Study protocol. / Callesen, Louise Bach; Hansen, Torben Frøstrup ; Andersen, Rikke Fredslund et al.
In: Acta Oncologica, Vol. 61, No. 9, 09.2022, p. 1152-1156.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer

T2 - a ctDNA-guided phase II randomised approach. Study protocol

AU - Callesen, Louise Bach

AU - Hansen, Torben Frøstrup

AU - Andersen, Rikke Fredslund

AU - Pallisgaard, Niels

AU - Kramer, Stine

AU - Schlander, Sven

AU - Rafaelsen, Søren Rafael

AU - Boysen, Anders Kindberg

AU - Jensen, Lars Henrik

AU - Jakobsen, Anders

AU - Spindler, Karen Lise Garm

PY - 2022/9

Y1 - 2022/9

KW - Circulating Tumor DNA

KW - Clinical Trials, Phase II as Topic

KW - Colorectal Neoplasms/drug therapy

KW - Follow-Up Studies

KW - Humans

KW - Patient Selection

U2 - 10.1080/0284186X.2022.2116728

DO - 10.1080/0284186X.2022.2116728

M3 - Comment/debate

C2 - 36094310

AN - SCOPUS:85138351992

SN - 0284-186X

VL - 61

SP - 1152

EP - 1156

JO - Acta Oncologica

JF - Acta Oncologica

IS - 9

ER -